Treatment for deadly superbug C. diff may be weakening
Thursday, 25 April 2024 ()
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research.
|
||||
You Might Like |
||||
